Prostamax

Prostamax is a bioregulatory peptide discussed for prostate-tissue support and local inflammatory balance, with the source protocol using a daily intramuscular route rather than the more common subcutaneous pattern.


Profile · 01

Overview

Prostamax is presented in the source as a prostate-focused bioregulatory peptide aimed at tissue support and inflammatory-balance signaling. It is part of the broader short-peptide bioregulator family rather than a classic receptor agonist or hormone analog.

This page is an edge case for the library because the source protocol uses intramuscular injection rather than subcutaneous injection. The content below preserves that route instead of forcing it into the wrong template.

At a Glance

Goal
Support prostate-tissue health and bioregulatory signaling in an experimental context
Categories
Prostate HealthBioregulationAnti-InflammatoryTissue Support
Synergistic
Epithalon · Thymalin · Vesugen · Prostatilen

Profile · 02

Protocol

Suggested daily intramuscular titration approach starting lower and increasing over the first month.

Reconstitute
Add 2.0 mL bacteriostatic water to a 20 mg vial for 10 mg/mL concentration
Typical daily range
500 mcg-1 mg once daily
Start
500 mcg daily for Weeks 1-2
Target
1 mg daily by Weeks 5-8
Frequency
Once daily (intramuscular)
Cycle Length
8-12 weeks with optional extension to 16 weeks
Timing
Any consistent time; rotate large muscle groups
Route
Intramuscular
Cycle
8-12 weeks on, 4 weeks off

Inject once daily intramuscularly using a very small volume. The source frames this as a prostate-support bioregulator rather than a hormone replacement or anti-androgen therapy, and the evidence base remains limited.

Dose progression

Weeks 1-2
500 mcg (0.5 mg) · 5 units (0.05 mL)
Weeks 3-4
750 mcg (0.75 mg) · 7.5 units (0.075 mL)
Weeks 5-8
1000 mcg (1.0 mg) · 10 units (0.10 mL)
Weeks 9-12
1000 mcg (1.0 mg) · 10 units (0.10 mL)

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.


Science · 01

How Prostamax works.

Prostamax is presented as a prostate-focused tissue bioregulator with proposed anti-inflammatory and local-support effects rather than a systemic endocrine therapy. The source places it alongside other organ-specific short peptides.

The evidence base remains limited and should be treated as exploratory. This is best viewed as a peptide-library educational summary rather than a clinically established prostate protocol.


Science · 02

Effects

Observations from clinical or preclinical literature.

May support prostate-tissue health and local inflammatory-balance goals in a research setting
Small injection volume keeps the practical route manageable despite intramuscular use
May fit alongside broader men's-health or tissue-support discussions
Human efficacy data remain limited
Local soreness or irritation may occur at injection sites

Science · 03

Caution

Use caution in active prostate cancer or unexplained urinary symptoms without qualified medical evaluation
Not recommended during pregnancy or breastfeeding because safety data is absent
Do not treat this as a substitute for prostate screening or standard care

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.


Lifestyle · 01

CoFactors

Zinc
Commonly discussed in prostate-health support contexts.
Omega-3 fatty acids
Support inflammatory-balance goals.
Vitamin D
Useful broader men's-health and immune-support marker.
Medical evaluation
Especially important when symptoms suggest BPH, prostatitis, or other pathology.

Lifestyle · 02

Life Factors

Complementary strategies for best outcomes.

Address urinary, pelvic, or hormonal symptoms with qualified evaluation rather than self-guessing
Use an anti-inflammatory diet pattern and maintain healthy body composition
Stay physically active and avoid prolonged sedentary time
Track urinary symptoms and comfort changes carefully if this page is being studied

Lifestyle · 03

Metrics

Day-to-day metrics worth tracking through the protocol.

  1. Urinary symptoms and comfort - useful for symptom-context tracking
  2. Pelvic discomfort or inflammatory symptoms - broader response context
  3. Injection-site soreness - especially relevant for intramuscular use

Lifestyle · 04

Labs

Baseline and periodic bloodwork to monitor systemic health during the protocol.

PSA
Only as clinically appropriate and interpreted with qualified medical guidance.
CBC (Complete Blood Count)
General baseline and follow-up monitoring.
CMP (Comprehensive Metabolic Panel)
Assesses liver and kidney function during the protocol.

Calculators · 01

Supplies Calculator

Estimates assume the schedule defined for this peptide.

Length
Vial size
Bac. water
Syringe
Vials
0 × 20 mg each
Syringes
0
Bac. water
0 mL
Swabs
02 per syringe

Calculators · 02

Dose Calculator

Dose Calculator

Vial
Bac. water
Syringe
Dose
Concentration
0mcg/mL
Volume per dose
0mL

Practice · 01

Preparation

Careful technique preserves potency. Solution should be clear — do not shake.

  1. Allow vial to reach room temperature for 15–20 minutes before reconstitution.
  2. Draw the chosen bacteriostatic water volume with a sterile syringe.
  3. Inject slowly down vial wall; avoid foaming.
  4. Gently swirl/roll until dissolved (do not shake).
  5. Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
  6. Use within 30 days; discard any unused solution after 30 days.

Practice · 02

Technique

General subcutaneous guidance from clinical best-practice resources.

Clean the vial stopper and skin with alcohol and allow them to dry fully
Use an appropriate intramuscular needle and inject into a large muscle such as the glute, vastus lateralis, or deltoid as appropriate
Insert at 90 degrees into the muscle using clean technique
Rotate injection sites to reduce soreness and local irritation
Discard used syringes and needles immediately in a sharps container

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.


Practice · 03

Storage

Lyophilized
Store at room temp in dry, dark conditions; minimize moisture exposure.
Reconstituted
Refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles. Discard reconstituted vials after 30 days.

Notes

Allow vials to reach room temperature before opening to reduce condensation uptake.

Reference · 01

Notes

This page uses an intramuscular route because that is what the source specifies
Use new sterile equipment for each injection and dispose of it safely
Do not use peptide experimentation as a substitute for prostate screening or medical evaluation
PepTribe is an educational platform. This information is for research and learning purposes only and is not medical advice.

Reference · 02

References

  1. Short-peptide bioregulator literature
    Background literature relevant to organ-specific bioregulator peptides.
    https://pubmed.ncbi.nlm.nih.gov/25482216/
  2. CDC
    General injection safety and route guidance.
    https://www.cdc.gov/injection-safety/hcp/clinical-safety/index.html
On this page